Drug Development

Listings

• 

  Anti-CD79b (clone ch10D10)-Mc-MMAF ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-CD79b monoclonal antibody (clone ch10D10) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocytosis...

• 

  Anti-CD79b (clone huMA79b.v28)-Mc-VC-PABC-MMAE ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated...

• 

  Anti-CD79b (clone huMA79b.v28)-BMPEO-DM1 ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a BMPEO linker to DM1. The DM1 is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocy...

• 

  Anti-CD79b (clone huMA79b.v28)-Mc-MMAF ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocyt...

• 

  Anti-CD79b (clone huMA79b.v18)-Mc-vc-PABC-MMAE ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a Mc-vc-PABC linker to MMAE. The MMAE is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated...

• 

  Anti-CD79b (clone huMA79b.v18)-BMPEO-DM1 ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a BMPEO linker to DM1. The DM1 is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocy...

• 

  Anti-CD79b (clone huMA79b.v18)-Mc-MMAF ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-CD79b monoclonal antibody (clone huMA79b.v18) conjugated via a Mc linker to MMAF. The MMAF is targeted to hematopoietic tumors by immunerecognition and delivered into cancer cells via receptor mediated endocyt...

• 

  Anti-MUC16 (clone 3A5)-VC-MMAE ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-MUC16 monoclonal antibody (clone thio hu 3A5) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....

• 

  Anti-MUC16 (clone 3A5)-VC-MMAE ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-MUC16 monoclonal antibody (clone std ch 3A5) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. ...

• 

  Anti-MUC16 (clone 3A5)-Mc-VC-PABC-MMAE ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-MUC16 monoclonal antibody (clone Thio ch 3A5) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endo...

• 

  Anti-MUC16 (clone 3A5)-Mc-VC-PABC-MMAE ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-MUC16 monoclonal antibody (clone std ch 3A5) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endoc...

• 

  Anti-EFNA4 (clone huE47)-AcBut-CM ADC

  Drug Development (United States ) September 25, 2020 Check with publisher

  This ADC product is comprised of an anti-EFNA4 monoclonal antibody (clone huE47)) conjugated via an AcBut linker to CM. The CM is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. http...